[go: up one dir, main page]

NO20012471L - Kaliumkanal-interaktorer og anvendelser derav - Google Patents

Kaliumkanal-interaktorer og anvendelser derav

Info

Publication number
NO20012471L
NO20012471L NO20012471A NO20012471A NO20012471L NO 20012471 L NO20012471 L NO 20012471L NO 20012471 A NO20012471 A NO 20012471A NO 20012471 A NO20012471 A NO 20012471A NO 20012471 L NO20012471 L NO 20012471L
Authority
NO
Norway
Prior art keywords
pcip
nucleic acid
acid molecules
proteins
potassium channel
Prior art date
Application number
NO20012471A
Other languages
English (en)
Other versions
NO20012471D0 (no
Inventor
Kenneth Rhodes
Maria Betty
Huai-Ping Ling
Wenqian An
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20012471D0 publication Critical patent/NO20012471D0/no
Publication of NO20012471L publication Critical patent/NO20012471L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det beskrives isolerte nukleinsyremolekyler, betegnet PCIP-nukleinsyremolekyler, som koder for proteiner som binder kaiiumkanaler og modulerer kaliumkanal-mediert aktiviteter. Videre beskrives antisense nukleinsyremolekyler, rekombinante ekspresjonsvektorer som inneholder PCIP-nukleinsyremolekyler, vertsceller som ekspresjonsvektorene er innført i samt ikke-humane transgene dyr, i hvilke et PCIP-gen er blitt innført eller forstyrret. Dessuten beskrives isolerte PCIP-proteiner, fusjonsproteiner, antigene peptider og anti-PCIP-antistoffer. Diagnostiske metoder som gjør bruk av de omtalte blandinger er også beskrevet.
NO20012471A 1998-11-20 2001-05-18 Kaliumkanal-interaktorer og anvendelser derav NO20012471L (no)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US11003398P 1998-11-25 1998-11-25
US11027798P 1998-11-30 1998-11-30
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor
PCT/US1999/027428 WO2000031133A2 (en) 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor

Publications (2)

Publication Number Publication Date
NO20012471D0 NO20012471D0 (no) 2001-05-18
NO20012471L true NO20012471L (no) 2001-07-18

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012471A NO20012471L (no) 1998-11-20 2001-05-18 Kaliumkanal-interaktorer og anvendelser derav

Country Status (12)

Country Link
EP (1) EP1131349A2 (no)
JP (1) JP2002530104A (no)
CN (1) CN1346368A (no)
AU (1) AU775713B2 (no)
BR (1) BR9915513A (no)
CA (1) CA2351365A1 (no)
CZ (1) CZ20011764A3 (no)
IL (1) IL143148A0 (no)
MX (1) MXPA01004903A (no)
NO (1) NO20012471L (no)
NZ (1) NZ512332A (no)
WO (1) WO2000031133A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
JP2004525610A (ja) * 2000-09-27 2004-08-26 ミレニアム ファーマスーティカルズ インク カリウムチャネル相互作用因子及びその利用方法
CN104316693A (zh) * 2008-11-06 2015-01-28 巴斯夫欧洲公司 杀虫剂的筛选测定法
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4758997A (en) * 1996-10-17 1998-05-11 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
NZ512332A (en) 2004-02-27
CA2351365A1 (en) 2000-06-02
AU775713B2 (en) 2004-08-12
CN1346368A (zh) 2002-04-24
JP2002530104A (ja) 2002-09-17
CZ20011764A3 (cs) 2002-01-16
WO2000031133A3 (en) 2000-10-05
MXPA01004903A (es) 2003-03-10
BR9915513A (pt) 2002-02-05
IL143148A0 (en) 2002-04-21
WO2000031133A2 (en) 2000-06-02
EP1131349A2 (en) 2001-09-12
AU1479700A (en) 2000-06-13
NO20012471D0 (no) 2001-05-18

Similar Documents

Publication Publication Date Title
NO20020861L (no) Nye B7-4-molekyler og anvendelser derav
WO1999043808A8 (en) Human c-maf compositions and methods of use thereof
ATE245189T1 (de) Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren
EP1798239A3 (en) G-protein coupled receptors and uses therefor
EP0804609A4 (en) NEW GENES OF RESPONSE p53
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO1999047686A3 (en) Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
DE60144021D1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
WO1997039721A3 (en) Methods and compositions for regulating t cell subsets by modulating transcription factor activity
WO2001073028A3 (en) A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
WO2000075358A3 (en) Mammalian toll homologues and uses thereof
NO20012471L (no) Kaliumkanal-interaktorer og anvendelser derav
WO2001087978A3 (en) Human abc transporter and its use
WO2002005843A3 (en) Human rrp sequences and methods of use
ATE308615T1 (de) T-bet zusammensetzungen und deren vervendungsmethoden
MXPA03002557A (es) Interactores de canales del potasio y sus usos.
WO2002070691A3 (en) Abcg4 transporter and uses thereof
WO2001094390A3 (en) 52906, 33408, and 12189, potassium channel family members and uses thereof
DK1328621T3 (da) 13245, en ny human proteinkinase af den myotoniske dystrofitype og anvendelser deraf
AU2001285204A1 (en) Atcr-1, a human acyltransferase and uses thereof
WO2002008395A3 (en) Putative human methyltransferase family member and uses thereof
WO2002020738A3 (en) 27877, a phospholipase and uses therefor
DK1029046T3 (da) WNT-1 inducerbare gener
WO2001096548A3 (en) Human n-acetyltransferase family member and uses thereof
EA200100566A1 (ru) Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application